After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed ...

Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...

BD is recognized as one of the leading medical technology companies worldwide, with a substantial market capitalization of $59.35 billion and annual revenue exceeding $20.6 billion. The company is ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the company’s outlook for the full year was close ...

After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes care business leave the nest. While reporting financial results for the ...

FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX), a prominent global medical technology firm, confirmed today the completion of its acquisition of Edwards Lifesciences (NYSE:EW)' ...

Dubai, United Arab Emirates – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will mark its presence at Arab ...

Becton Dickinson & Co. is set to make additional investments in its U.S. manufacturing network to add capacity for critical medical devices. “BD has a longstanding history as a leading U.S.